Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting.
<h4>Rationale</h4>Murine syngeneic tumor models have revealed efficacious systemic antitumor responses following primary tumor in situ vaccination combined with targeted radionuclide therapy to secondary or metastatic tumors. Here we present studies on the safety and feasibility of this...
Guardado en:
Autores principales: | Kara Magee, Ian R Marsh, Michelle M Turek, Joseph Grudzinski, Eduardo Aluicio-Sarduy, Jonathan W Engle, Ilene D Kurzman, Cindy L Zuleger, Elizabeth A Oseid, Christine Jaskowiak, Mark R Albertini, Karla Esbona, Bryan Bednarz, Paul M Sondel, Jamey P Weichert, Zachary S Morris, Reinier Hernandez, David M Vail |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/614577853cda400990756e8aa63b13c4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- Clavier companion
- Molecular imaging and radionuclide therapy
-
Nephrotoxicity after radionuclide therapies
por: Ashwin Singh Parihar, et al.
Publicado: (2022) -
Radionuclide carriers for targeting of cancer
por: Stavroula Sofou
Publicado: (2008) -
Immuno-genomic landscape of osteosarcoma
por: Chia-Chin Wu, et al.
Publicado: (2020)